We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$318B
AUM Growth
+$15.6B
Cap. Flow
-$1.79B
Cap. Flow %
-0.56%
Top 10 Hldgs %
17.75%
Holding
4,003
New
124
Increased
1,958
Reduced
1,647
Closed
117

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$1.42B
2
JNJ icon
Johnson & Johnson
JNJ
+$685M
3
SLB icon
SLB Ltd
SLB
+$281M
4
MDLZ icon
Mondelez International
MDLZ
+$241M
5
BABA icon
Alibaba
BABA
+$229M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$377M
2
WBA
Walgreens Boots Alliance
WBA
+$296M
3
AMGN icon
Amgen
AMGN
+$278M
4
GGP
GGP Inc.
GGP
+$250M
5
EA icon
Electronic Arts
EA
+$250M

Sector Composition

Rank Sector Weight
1 Technology 19.74%
2 Financials 13.21%
3 Healthcare 12.3%
4 Consumer Discretionary 11.6%
5 Communication Services 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENZ
3701
DELISTED
Enzo Biochem, Inc.
ENZ
$46K ﹤0.01%
11,253
-1,569
-12% -$7.13K
AGEN
3702
Agenus
AGEN
$276M
$43K ﹤0.01%
1,020
+257
+34% +$10.1K
CVRS
3703
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$42K ﹤0.01%
29,415
-5,105
-15% -$5.59K
TEUM
3704
DELISTED
Pareteum Corporation
TEUM
$41K ﹤0.01%
+13,727
New +$37K
DMK
3705
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$40K ﹤0.01%
+165
New +$39.1K
CARM
3706
DELISTED
Carisma Therapeutics
CARM
$39K ﹤0.01%
909
-27
-3% -$1.05K
TLRA
3707
DELISTED
Telaria, Inc.
TLRA
$39K ﹤0.01%
10,318
-1,343
-12% -$5.2K
LEE icon
3708
Lee Enterprises
LEE
$175M
$38K ﹤0.01%
1,433
-249
-15% -$7.32K
INFI
3709
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$37K ﹤0.01%
13,501
-2,043
-13% -$4.23K
CTIC
3710
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$37K ﹤0.01%
17,249
-384
-2% -$951
IMDZ
3711
DELISTED
Immune Design Corp.
IMDZ
$36K ﹤0.01%
10,406
-1,383
-12% -$5.19K
EGY icon
3712
Vaalco Energy
EGY
$562M
$35K ﹤0.01%
12,836
-2,106
-14% -$5.55K
TRVN
3713
DELISTED
Trevena, Inc.
TRVN
$34K ﹤0.01%
25
-1
-4% -$1.01K
TYME
3714
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$31K ﹤0.01%
+11,226
New +$29.3K
DXLG icon
3715
Destination XL Group
DXLG
$32.9M
$28K ﹤0.01%
11,237
-1,917
-15% -$4.4K
MVIS icon
3716
Microvision
MVIS
$84.8M
$28K ﹤0.01%
23,368
-4,155
-15% -$4.34K
PLX icon
3717
Protalix BioTherapeutics
PLX
$183M
$27K ﹤0.01%
3,729
-564
-13% -$2.83K
ROX
3718
DELISTED
Castle Brands, Inc.
ROX
$27K ﹤0.01%
25,535
-3,864
-13% -$4.4K
ZN
3719
DELISTED
Zion Oil & Gas, Inc.
ZN
$26K ﹤0.01%
20,222
-8,769
-30% -$20.5K
AXAS
3720
DELISTED
Abraxas Petroleum Corp
AXAS
$25K ﹤0.01%
538
+28
+5% +$1.37K
FTF.RT
3721
DELISTED
Franklin Limited Duration Income Trust Rights (expiring October 18, 2018)
FTF.RT
$25K ﹤0.01%
+280,033
New +$54K
STCN
3722
DELISTED
Steel Connect, Inc. Common Stock
STCN
$23K ﹤0.01%
1,157
-175
-13% -$3.43K
ZOM
3723
DELISTED
Zomedica Corp.
ZOM
$23K ﹤0.01%
+12,511
New +$26.8K
QUIK icon
3724
QuickLogic
QUIK
$211M
$22K ﹤0.01%
1,594
-364
-19% -$5.52K
FBIO icon
3725
Fortress Biotech
FBIO
$111M
$21K ﹤0.01%
870
+50
+6% +$1.6K

Similar funds

Invesco's Q3 2018 Portfolio in Review

As of Q3 2018, Invesco held 4,003 positions worth $318B, up 5.2% from $302B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Invesco's Q3 2018 filing shows 124 new, 1,958 increased, 1,647 reduced and 117 closed positions. Its largest new stake was Hanger Inc.: 3,856,471 shares worth $80.3M. The largest sale was Pfizer, an estimated $377M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Invesco's largest Q3 2018 buy was Hanger Inc.: 3,856,471 shares worth $80.3M.
  • Invesco added most to PepsiCo in Q3 2018, an estimated $1.42B increase.
  • Invesco's biggest Q3 2018 reduction was Pfizer, cutting an estimated $377M.
  • Invesco fully exited GGP Inc. in Q3 2018, selling an estimated $250M.
  • Invesco's ten largest holdings make up 18% of its $318B portfolio in Q3 2018.
  • Invesco opened 124 new positions and closed 117 in Q3 2018.
  • Invesco's portfolio value rose 5.2% quarter-over-quarter to $318B.

Based on Invesco's 13F filing for Q3 2018, filed 14 Nov 2018.